Che-Ming Yeh

Title: Che-Ming Yeh: Innovator in Metabolic Disorder Treatments

Introduction

Che-Ming Yeh is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the treatment of metabolic disorders. His innovative approach has led to the development of methods that utilize recombinant proteins for therapeutic purposes.

Latest Patents

Che-Ming Yeh holds a patent for the "Use of recombinant protein for treating metabolic disorders." This patent discloses methods and compositions that are useful in preventing or treating metabolic disorders by employing a protein with a specific amino acid sequence as set forth in SEQ ID NO: 1. This groundbreaking work highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Che-Ming Yeh has been associated with Eu Sol Biotech Co., Ltd., where he has played a crucial role in research and development. His expertise in biotechnology has positioned him as a key figure in the industry, contributing to innovative solutions for complex health issues.

Collaborations

Che-Ming Yeh has collaborated with notable colleagues, including Jin-Ding Huang and Wan-Ya Chang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of new technologies.

Conclusion

Che-Ming Yeh's work in the field of metabolic disorder treatments exemplifies the impact of innovation in biotechnology. His contributions through patents and collaborations continue to pave the way for advancements in medical science.